Literature DB >> 26655190

Significant association of GRM7 and GRM8 genes with schizophrenia and major depressive disorder in the Han Chinese population.

Wenjin Li1, Kang Ju2, Zhiqiang Li1, Kuanjun He1, Jianhua Chen3, Qingzhong Wang1, Beimeng Yang1, Lin An1, Guoyin Feng4, Weiming Sun1, Juan Zhou1, Shasha Zhang1, Pingping Song5, Raja Amjad Waheed Khan1, Weidong Ji6, Yongyong Shi7.   

Abstract

Metabotropic glutamate receptor type 7 (GRM7) and type 8 (GRM8) are involved in the neurotransmission of glutamate which is supposed to play an important role in the development of schizophrenia (SCZ) and major depressive disorders (MDD). We designed this study to investigate whether common DNA variants or their genetic interactions within GRM7 and GMR8 genes were associated with these disorders in the Han Chinese population. Fourteen SNPs in GRM7 and GRM8 were selected within a sample set comprising 1235 SCZ patients, 1045 MDD patients and 1235 normal controls. Significant association in SCZ case-control subjects was observed for rs2229902 (permutated Pallele=0.0005, OR=1.492 [95% CI=1.231-1.807]) and rs9870680 (permutated Pallele=0.0023, OR=1.262 [95% CI=1.116-1.426]) in GRM7 and rs2237781 (permutated Pallele=0.0027, OR=1.346 [95% CI=1.149-1.575]) in GRM8. Association analysis for MDD case-control subjects revealed positive results in rs779706 (permutated Pallele=0.0099, OR=1.237 [95% CI=1.093-1.399]) of GRM7 and in rs1361995 (permutated Pallele=0.0017, OR=1.488 [95% CI=1.215-1.823]) of GRM8. Moreover, a three-locus model, constituted by polymorphisms in GRM7 and GRM8 significantly correlated with MDD in the gene-gene interaction analysis. Meta-analysis and haplotype analysis further confirmed our significant results. We demonstrated the genetic association of GRM7 and GRM8 with SCZ and MDD in the Han Chinese population. We also found susceptibility interactive effects of these two genes with both psychiatric disorders, which might provide new insights into the etiology of them.
Copyright © 2015 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  Association; GRM7; GRM8; Major depressive disorder; SNP; Schizophrenia

Mesh:

Substances:

Year:  2015        PMID: 26655190     DOI: 10.1016/j.euroneuro.2015.05.004

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  11 in total

1.  Discovery of VU6027459: A First-in-Class Selective and CNS Penetrant mGlu7 Positive Allosteric Modulator Tool Compound.

Authors:  Carson W Reed; Jacob J Kalbfleisch; Madison J Wong; Jordan P Washecheck; Ashton Hunter; Alice L Rodriguez; Anna L Blobaum; P Jeffrey Conn; Colleen M Niswender; Craig W Lindsley
Journal:  ACS Med Chem Lett       Date:  2020-08-20       Impact factor: 4.345

2.  GRM7 polymorphisms and risk of schizophrenia in Iranian population.

Authors:  Iman Azari; Reza Hosseinpour Moghadam; Hamid Fallah; Rezvan Noroozi; Soudeh Ghafouri-Fard; Mohammad Taheri
Journal:  Metab Brain Dis       Date:  2019-01-04       Impact factor: 3.584

3.  Loss-of-Function Models of the Metabotropic Glutamate Receptor Genes Grm8a and Grm8b Display Distinct Behavioral Phenotypes in Zebrafish Larvae (Danio rerio).

Authors:  Teresa M Lüffe; Moritz Bauer; Zoi Gioga; Duru Özbay; Marcel Romanos; Christina Lillesaar; Carsten Drepper
Journal:  Front Mol Neurosci       Date:  2022-06-13       Impact factor: 6.261

Review 4.  Metabotropic Glutamate Receptors As Emerging Targets for the Treatment of Schizophrenia.

Authors:  Shalini Dogra; P Jeffrey Conn
Journal:  Mol Pharmacol       Date:  2022-03-03       Impact factor: 4.054

Review 5.  A Systematic Review of Candidate Genes for Major Depression.

Authors:  Audrone Norkeviciene; Romena Gocentiene; Agne Sestokaite; Rasa Sabaliauskaite; Daiva Dabkeviciene; Sonata Jarmalaite; Giedre Bulotiene
Journal:  Medicina (Kaunas)       Date:  2022-02-14       Impact factor: 2.430

6.  TCF4 and GRM8 gene polymorphisms and risk of schizophrenia in an Iranian population: a case-control study.

Authors:  Javad Tavakkoly-Bazzaz; Asaad Azarnezhad; Negar Mousavi; Pouya Salehipour; Esmaeil Shahsavand Ananloo; Fatemeh Alizadeh
Journal:  Mol Biol Rep       Date:  2018-10-04       Impact factor: 2.316

7.  Discovery of VU6005649, a CNS Penetrant mGlu7/8 Receptor PAM Derived from a Series of Pyrazolo[1,5-a]pyrimidines.

Authors:  Masahito Abe; Mabel Seto; Rocco G Gogliotti; Matthew T Loch; Katrina A Bollinger; Sichen Chang; Eileen M Engelberg; Vincent B Luscombe; Joel M Harp; Michael Bubser; Darren W Engers; Carrie K Jones; Alice L Rodriguez; Anna L Blobaum; P Jeffrey Conn; Colleen M Niswender; Craig W Lindsley
Journal:  ACS Med Chem Lett       Date:  2017-09-01       Impact factor: 4.345

8.  A 7q31.33q32.1 microdeletion including LRRC4 and GRM8 is associated with severe intellectual disability and characteristics of autism.

Authors:  Noriko Sangu; Keiko Shimojima; Yuya Takahashi; Tsukasa Ohashi; Jun Tohyama; Toshiyuki Yamamoto
Journal:  Hum Genome Var       Date:  2017-02-09

9.  TS: a powerful truncated test to detect novel disease associated genes using publicly available gWAS summary data.

Authors:  Jianjun Zhang; Xuan Guo; Samantha Gonzales; Jingjing Yang; Xuexia Wang
Journal:  BMC Bioinformatics       Date:  2020-05-04       Impact factor: 3.169

10.  Negative Allosteric Modulators of mGlu7 Receptor as Putative Antipsychotic Drugs.

Authors:  Paulina Cieślik; Monika Woźniak; Katarzyna Kaczorowska; Piotr Brański; Grzegorz Burnat; Agnieszka Chocyk; Bartosz Bobula; Piotr Gruca; Ewa Litwa; Agnieszka Pałucha-Poniewiera; Agnieszka Wąsik; Andrzej Pilc; Joanna Wierońska
Journal:  Front Mol Neurosci       Date:  2018-09-20       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.